bluenote-cover-image

Bluenote is transforming the status quo by enabling life sciences organizations to accelerate the most laborious aspects of their operations. Bluenote’s AI platform for life sciences is driving the industry’s shift to AI-first operations. From content automation for pre-clinical study reports, INDs, NDAs, BLAs, CSRs, CMC and PMAs, to AI agents for lab operations and quality, to analysis over protocols and vast experimental data, Bluenote is accelerating mission-critical workflows by 50-75%.

Nulla adipisicing do ut aliquip elit tempor fugiat. Mollit est exercitation excepteur ea consequat ullamco Lorem ex id. Ipsum nostrud Lorem dolor nisi do est in ex amet eu nostrud. Amet commodo consectetur enim nostrud dolore sint excepteur irure aliqua consectetur. Veniam occaecat et enim eiusmod qui fugiat eiusmod eiusmod laborum exercitation veniam ipsum velit. Ut veniam cupidatat ea tempor ad ad exercitation amet qui. Esse commodo sint deserunt ut elit minim sint. Amet laborum ut adipisicing minim sunt cillum anim in est ipsum aliquip anim in tempor pariatur.

industries
Milestones

Lux investment: 2025

Founders

Fatima Sabar

Lux partners
Deena Shakir

Bluenote

Laurence Pevsner
Nat Turner
David Yang
Kim Tran
Tess van Stekelenburg
Andrew Wilson
Tracie Rotter
Stevie Lee
Steven Brody
Shaq Vayda
Shahin Farshchi, PhD
Segolene Scarborough
Sean Traynor
Scott Rubin
Samuel Arbesman, PhD
Samantha Cho
Peter Hébert
Lindsay Morris
Lan Jiang
Josh Wolfe
Grace Isford
Deena Shakir
Debbie Elsen
Danny Crichton
Cristina Morris
Brandon Reeves
Brad Gritsch
Bibi Masara
Adam Kalish